263 related articles for article (PubMed ID: 20971717)
1. Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions.
Smith V; De Keyser F; Pizzorni C; Van Praet JT; Decuman S; Sulli A; Deschepper E; Cutolo M
Ann Rheum Dis; 2011 Jan; 70(1):180-3. PubMed ID: 20971717
[TBL] [Abstract][Full Text] [Related]
2. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity.
Caramaschi P; Canestrini S; Martinelli N; Volpe A; Pieropan S; Ferrari M; Bambara LM; Carletto A; Biasi D
Rheumatology (Oxford); 2007 Oct; 46(10):1566-9. PubMed ID: 17693443
[TBL] [Abstract][Full Text] [Related]
3. Capillaroscopy.
Cutolo M; Pizzorni C; Secchi ME; Sulli A
Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):1093-108. PubMed ID: 19041079
[TBL] [Abstract][Full Text] [Related]
4. The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis.
Yalcinkaya Y; Pehlivan O; Omma A; Alpay N; Erer B; Kamali S; Ocal L; Inanc M
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S92-7. PubMed ID: 25797836
[TBL] [Abstract][Full Text] [Related]
5. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
Ingegnoli F; Boracchi P; Gualtierotti R; Lubatti C; Meani L; Zahalkova L; Zeni S; Fantini F
Arthritis Rheum; 2008 Jul; 58(7):2174-82. PubMed ID: 18576359
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
[TBL] [Abstract][Full Text] [Related]
7. Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study.
Smith V; Pizzorni C; De Keyser F; Decuman S; Van Praet JT; Deschepper E; Sulli A; Cutolo M
Ann Rheum Dis; 2010 Jun; 69(6):1092-6. PubMed ID: 20439291
[TBL] [Abstract][Full Text] [Related]
8. [Nailfold capillaroscopy in children and adolescents with rheumatic diseases].
Petry DG; Terreri MT; Len CA; Hilário MO
Acta Reumatol Port; 2008; 33(4):395-400. PubMed ID: 19107084
[TBL] [Abstract][Full Text] [Related]
9. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.
Smith V; Riccieri V; Pizzorni C; Decuman S; Deschepper E; Bonroy C; Sulli A; Piette Y; De Keyser F; Cutolo M
J Rheumatol; 2013 Dec; 40(12):2023-8. PubMed ID: 24128778
[TBL] [Abstract][Full Text] [Related]
10. Reliability of widefield nailfold capillaroscopy and video capillaroscopy in the assessment of patients with Raynaud’s phenomenon.
Sekiyama JY; Camargo CZ; Eduardo L; Andrade C; Kayser C
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1853-61. PubMed ID: 23754794
[TBL] [Abstract][Full Text] [Related]
11. Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study.
Riccieri V; Vasile M; Iannace N; Stefanantoni K; Sciarra I; Vizza CD; Badagliacca R; Poscia R; Papa S; Mezzapesa M; Nocioni M; Valesini G
Rheumatology (Oxford); 2013 Aug; 52(8):1525-8. PubMed ID: 23671125
[TBL] [Abstract][Full Text] [Related]
12. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
13. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy.
Ingegnoli F; Boracchi P; Gualtierotti R; Biganzoli EM; Zeni S; Lubatti C; Fantini F
Rheumatology (Oxford); 2010 Apr; 49(4):797-805. PubMed ID: 20100796
[TBL] [Abstract][Full Text] [Related]
14. Capillary density: An important parameter in nailfold capillaroscopy.
Emrani Z; Karbalaie A; Fatemi A; Etehadtavakol M; Erlandsson BE
Microvasc Res; 2017 Jan; 109():7-18. PubMed ID: 27614146
[TBL] [Abstract][Full Text] [Related]
15. Feet nailfold capillaroscopy is not useful to detect the typical scleroderma pattern.
Batticciotto A; Atzeni F; Foglia S; Antivalle M; Serafin A; Sarzi-Puttini P
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S116-7. PubMed ID: 22691219
[No Abstract] [Full Text] [Related]
16. Nailfold capillaroscopy and classification criteria for systemic sclerosis.
Cutolo M; Matucci Cerinic M
Clin Exp Rheumatol; 2007; 25(5):663-5. PubMed ID: 18078610
[No Abstract] [Full Text] [Related]
17. Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy.
Akay BN; Sanli H; Topcuoglu P; Arat M; Akyol A
Br J Dermatol; 2010 May; 162(5):1076-82. PubMed ID: 20222922
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal nailfold capillaroscopy tracking of microangiopathic changes in systemic sclerosis.
Dinsdale G; van Roon AM; Murray A; Taylor C; Herrick AL
Rheumatology (Oxford); 2018 Sep; 57(9):1554. PubMed ID: 29506240
[No Abstract] [Full Text] [Related]
19. Timing of transition between capillaroscopic patterns in systemic sclerosis.
Sulli A; Pizzorni C; Smith V; Zampogna G; Ravera F; Cutolo M
Arthritis Rheum; 2012 Mar; 64(3):821-5. PubMed ID: 22127901
[TBL] [Abstract][Full Text] [Related]
20. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study.
Smith V; Decuman S; Sulli A; Bonroy C; Piettte Y; Deschepper E; de Keyser F; Cutolo M
Ann Rheum Dis; 2012 Oct; 71(10):1636-9. PubMed ID: 22402146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
